The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
Open accessAbstract
Microglia maintain homeostasis in the central nervous system through phagocytic clearance of protein aggregates and cellular debris. This function deteriorates during ageing and neurodegenerative disease, concomitant with cognitive decline. However, the mechanisms of impaired microglial homeostatic function and the cognitive effects of restoring this function remain unknown. We combined CRISPR-Cas9 knockout screens with RNA sequencing analysis to discover age-related genetic modifiers of microglial phagocytosis. These screens identified CD22, a canonical B cell receptor, as a negative regulator of phagocytosis that is upregulated on aged microglia. CD22 mediates the anti-phagocytic effect of α2,6-linked sialic acid, and inhibition of CD22 promotes the clearance of myelin debris, amyloid-β oligomers and α-synuclein fibrils in vivo. Long-term central nervous system delivery of an antibody that blocks CD22 function reprograms microglia towards a homeostatic transcriptional state and improves cognitive function in aged mice. These findings elucidate a mechanism of age-related microglial impairment and a strategy to restore homeostasis in the ageing brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“restoration of microglial phagocytosis improved cognitive function in aged mice and promoted a homeostatic microglial transcriptional signature78.”
From Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease (2025) · cites this paper as [78]
In the citing paper
“These were strongly enriched for up-regulated genes with immune-modulatory functions (Table S5), including MHC I-mediated antigen presentation, interferon-response, cell adhesion and complement cascade, as well as regulators of mouse microglia activity (Figure 2C) including Cd22 (Pluvinage et al., 2019), Trem2 and Tyrobp (Yeh et al., 2017).”
From Atlas of the aging mouse brain reveals white matter as vulnerable foci (2023) · cites this paper as Pluvinage et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
The Tabula Muris Consortium, coordination, O., coordination, L., processing, O. C. A., sequencing, L. P. A., analysis, C. D., annotation, C. T., Writing group, Supplemental text writing group, & Principal investigators (2018) · Nature · doi:10.1038/s41586-018-0590-4 · Cited by 2,842
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Cited by
Sorted by citations
Items 301–400 of 467
Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention
Zhang, B., Li, X., Yin, T., Qin, D., Chen, Y., Ma, Q., Shu, P., & Wang, Y. (2022) · Journal of Oncology · doi:10.1155/2022/4259205 · Cited by 8
Yang, J., Qu, J., & Ma, H. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.03 · Cited by 7
Sex-oriented perspectives in immunopharmacology
Cignarella, A., Vegeto, E., Bolego, C., Trabace, L., Conti, L., & Ortona, E. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106956 · Cited by 7
Wang, J., Xie, N., Lu, S., Xiao, B., Ou, Y., Li, Q., Liu, D., & Zhou, W. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202403469 · Cited by 8
Lu, J., Zhou, Q., Zhu, D., Song, H., Xie, G., Zhao, X., Huang, Y., Cao, P., Wang, J., & Shen, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.010 · Cited by 7
“1) as a voltage-gated potassium channel is composed of four a subunits (S1 e S4, voltage-sensor domain; S5 e S6, pore domain) and widely distributed in the CNS.”
InfluentialCD22 modulation alleviates amyloid β-induced neuroinflammation
Mai, Y. D., Zhang, Q., Fung, C. L., Leung, S. O., & Chong, C. H. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03361-2 · Cited by 7
IL-4 induces CD22 expression to restrain the effector program of virtual memory T cells
Yang, B., Piedfort, O., Sanchez, G. S., Lavergne, A., Gong, M., Peng, G., Madrigal, A., Petrellis, G., Katsandegwaza, B., Rodriguez-Rodriguez, L., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adk4841 · Cited by 7
Liu, L., Xiao, F., Yang, J., Yao, H.-Q., & Hua, K. Q. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156893 · Cited by 7
Neuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 9
He, W., Zhang, L., Zheng, D., Tang, L., Zhang, Y., Peng, M., Wang, Z., Xu, C., Chen, Z., Liu, Y., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.04.026 · Cited by 7
Zhu, X.-L., Zhang, H., Peng, W., Gao, S., Yang, Z., Zhang, J., & Liu, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.067 · Cited by 7
Increased α-2,6 sialic acid on microglia in amyloid pathology is resistant to oseltamivir
Fastenau, C., Wickline, J. L., Smith, S. A., Odfalk, K. F., Solano, L., Bieniek, K. F., & Hopp, S. C. (2023) · GeroScience · doi:10.1007/s11357-023-00761-1 · Cited by 7
Calcium Signalling in Microglia
Garaschuk, O., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_7 · Cited by 7
Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics
Prescher, H., Schweizer, A., Frank, M., Kuhfeldt, E., Ring, J., & Nitschke, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00765 · Cited by 7
Multiple roles of neuronal extracellular vesicles in neurological disorders
Jiao, Z., He, Z., Liu, N., Lai, Y., & Zhong, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.979856 · Cited by 7
Peradinović, J., Mohovic, N., Bulic, K., Markovinović, A., Cimbro, R., & Munitić, I. (2023) · Biology · doi:10.3390/biology12020240 · Cited by 6
“It is thus not surprising that they have been shown to degenerate and become less functional with age [30].”
BackgroundMartín, M., Pusceddu, M. M., Teichenne-Jané, J., Negra, T., Connolly, A., Escoté, X., Torrell-Galceran, H., Cereto‐Massagué, A., Samarra, I., Delpino-Rius, A., et al. (2023) · Nutrients · doi:10.3390/nu15132854 · Cited by 7
“Thereby, sustained microglia activation increases synapse pruning, produces inflammation, and creates a toxic environment that threatens correct neuronal functionality leading to impairments in the learning and memory processes [7,8].”
BackgroundGene-set Enrichment with Regularized RegressionPreprint
Fang, T., Davydov, I. I., Marbach, D., & Zhang, J. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/659920 · Cited by 7
“…such as single-cell omics (Sturm et al., 2019), spatial omics (Rodriques et al., 2019) and functional genomic screening (Haney etal., 2018; Pluvinage et al., 2019) are enriching our knowledge in cell-type and cell-state-specific gene expression and function at an unprecedented rate, we…”
BackgroundInvestigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease
Iovino, L., VanderZwaag, J., Kaur, G., Khakpour, M., Giusti, V., Donadon, M., Chiavegato, A., Lopes, L. T., Greggio, E., Tremblay, M., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106481 · Cited by 7
“…chronic stress, infection, aging, and degeneration, for example, microglia may begin to over-phagocytose the parenchyma resulting in behavioral, cognitive, and emotional deficits (Bassett et al., 2021; Bollinger and Wohleb, 2019; Haruwaka et al., 2019; Pluvinage et al., 2019; Wohleb et al., 2018).”
BackgroundMapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases
He, Q., Wang, Y., Tan, Z., Zhang, X., Yu, C., & Jiang, X. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1558432 · Cited by 6
Construction of ROS-responsive cascade-targeted liposomes and investigation of their anti-AD effects
Yu, J., Ma, D., Li, S., Yang, S., Li, T., Kong, L., Liu, Y., Zang, J., Yu, Y., & Li, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115234 · Cited by 6
Central Nervous System Developmental Regulation of Microglia via Cytokines and Chemokines
Shigemoto‐Mogami, Y., & Sato, K. (2021) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.20-00198-4 · Cited by 6
Microbial and immune factors regulate brain maintenance and aging
Travier, L., Singh, R., Fernández, D. S., & Deczkowska, A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102607 · Cited by 6
In vitro and in vivo CRISPR-Cas9 screens reveal drivers of aging in neural stem cells of the brainPreprint
Ruetz, T. J., Kashiwagi, C. M., Morton, B., Yeo, R. W., Leeman, D. S., Morgens, D. W., Tsui, C. K., Li, A., Bassik, M. C., & Brunet, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.23.469762 · Cited by 9
Self-citationBar, E., Fischer, I., Rokach, M., Elad‐Sfadia, G., Shirenova, S. D., Ophir, O., Trangle, S. S., Okun, E., & Barak, B. (2024) · Glia · doi:10.1002/glia.24519 · Cited by 5
“Subsequently, we induced in vitro phagocytosis using labeled myelin and assessed microglial phagocytic capacity (Nicola et al., 2022; Pluvinage et al., 2019) using Incucyte.”
MethodHAPLN2 forms aggregates and promotes microglial inflammation during brain aging in mice
Watanabe, A., Hirayama, S., Kominato, I., Marchese, S., Esposito, P., Metodieva, V., Kimura, T., Kameda, H., Sano, T., Takao, M., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003006 · Cited by 7
The Critical Role of Autophagy and Phagocytosis in the Aging Brain
Bondy, S. C., & Wu, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010057 · Cited by 5
“Impeding this receptor in aged mice with an antibody enhances the clearance of myelin debris and of amyloid-β peptide aggregates, and also improves behavioral functioning [19].”
Pei, M.-Q., Xu, L., Yang, Y.-S., Chen, W.-C., Chen, X.-L., Fang, Y.-M., Lin, S., & He, H. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148821 · Cited by 6
Gautam, R. K., Tripathi, S. M., Akash, S., Sharma, S., Sharma, K., Goyal, S., Behzad, S., Gundamaraju, R., Mishra, D. K., Zhang, Y., et al. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673291064240227094654 · Cited by 5
Astrocyte interleukin-3 preps microglia
Klein, R. S. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.09.008 · Cited by 5
Dai, W., Yao, R., Mi, T., Zhang, L., Wu, H., Cheng, J., & Li, Y.-F. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221122008 · Cited by 6
“Instead, enhancing the phagocytic function of microglia could effectively improve the cognitive function of AD and aging mice (Pluvinage et al., 2019).”
BackgroundEnikanolaiye, A., Ruston, J., Zeng, R., Taylor, C., Schrock, M., Buchovecky, C. M., Shendure, J., Acar, E. F., & Justice, M. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/810929 · Cited by 5
“2018), and antibodies directed against CD22 reduce microglial impairment in ageing brains (Pluvinage et al. 2019).”
BackgroundDelaveris, C. S., Wang, C. L., Riley, N. M., Li, S., Kulkarni, R. U., & Bertozzi, C. R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.21.554214 · Cited by 5
Self-citationLessons from ex vivo and in vitro models in microglia research
Cserép, C., Berki, P., Mars, M., Pósfai, B., Pasterkamp, R. J., Benkő, S., & Dénes, Á. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.10.004 · Cited by 5
Sialylation in the nervous system: Functions and mechanisms
Koles, K., Repnikova, E. A., Novikov, B., & Panin, V. M. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111288 · Cited by 6
“…effect of CD22 is mediated by interactions with α 2-6–linked sialylated ligands, and inhibition of CD22 can restore microglial homeostatic functions in the aging brain, promoting the clearance of myelin debris and removal of pathogenic α -synuclein fibrils and beta-amyloid (A β ) oligomers (109).”
Zhou, Z., Li, X., Wang, Y., Liang, L., Wang, C., Sun, Y., Wu, D., & Qiu, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-69996-8 · Cited by 4
ZHAO, J.-F., JIANG, Y.-R., GUO, T.-L., JIAO, Y.-Q., & WANG, X. (2024) · Biocell · doi:10.32604/biocell.2024.050120 · Cited by 4
“…of patients with advanced AD, due to excessive A β , microglia can be transformed into M1 type and secrete a large number of in fl ammatory factors as well as ROS to damage neurons [106], increasing the phagocytosis of microglia has been shown to improve cognitive dysfunction in AD patients [107].”
Jana, R., & Sarma, J. D. (2025) · Biogerontology · doi:10.1007/s10522-025-10213-2 · Cited by 4
“Together, this suggests that different stages of phagocytic pathways are affected by aging, ranging from receptor-mediated myelin uptake and myelin degradation to reverse cholesterol transport (Pluvinage et al. 2019; Cantuti-Castelvetri et al. 1979).”
Wang, G., Han, Y., Peng, K., Jiang, Z., Wang, T., Zheng, Q., Li, W., Xu, H., Ji, F., & Li, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101714 · Cited by 4
“To determine the potential of CSPA NPs to mitigate microglial-mediated synapse elimination in vitro [61], BV2 cells were cultured with fluorescent beads to assess phagocytosis.”
Folarin, O. R., Olopade, F. E., Gilbert, T. T., Ladagu, A. D., Santos, P. I., Mustapha, O., Kpasham, L. Z., Olopade, J. O., & Outeiro, T. F. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70082 · Cited by 4
Ting, S., Zhao, X., Sun, G., Ricote, M., & Aronowski, J. A. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0248-25.2025 · Cited by 4
Yang, Y., Wang, J., Ni, H., Ding, H., Wei, L., & Ke, Z. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148566 · Cited by 4
The microRNA-mediated gene regulatory network in the hippocampus and hypothalamus of the aging mouse
Munkhzul, C., Yi, S. S., Kim, J., Lee, S., Kim, H.-T., Moon, J., & Lee, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291943 · Cited by 4
Tang, X., Schindler, R. L., Lucente, J. D., Oloumi, A., Tena, J., Harvey, D. J., Lebrilla, C. B., Zivkovic, A. M., Jin, L., & Maezawa, I. (2025) · Scientific Reports · doi:10.1038/s41598-025-96596-1 · Cited by 6
“Neuronal membranes contain a high density of sialic acid residues on glycoproteins, which protect neurons from aberrant microglial phagocytosis 57 via interacting with Siglec receptors such as CD22 and CD33 on microglia 58–60 .”
Beiter, R. M., Raghavan, T. P., Suchocki, O., Ennerfelt, H. E., Rivet-Noor, C. R., Merchak, A. R., Phillips, J. L., Bathe, T., Lukens, J. R., Prokop, S., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41635 · Cited by 4
“C57BL/6J mice (8 – 14 weeks) were injected with 1 μ l of CypHer-A β (1 mg/ml, ipsilateral) and NHS-Fluorescein (contralateral, Thermo Fisher 46410) as previously described [51].”
The mechanism of disease progression by aging and age-related gut dysbiosis in multiple sclerosis
Yadav, S. K., Chen, C., Dhib-Jalbut, S. S., & Ito, K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106956 · Cited by 4
“Additionally, CD22, a negative regulator of phagocytosis, is upregulated in aged microglia (Pluvinage et al., 2019), suggesting that CD22 could be a therapeutic target for neurodegenerative diseases, including MS.”
Interaction between neurons and microglia in healthy and disease states
Nakamura, A., & Shichita, T. (2025) · International Immunology · doi:10.1093/intimm/dxaf057 · Cited by 5
Microglia as a key mediator in rosuvastatin-associated cognitive impairment
Sang, X., Ye, Y., Yang, C., Hou, X., Guo, Y., Shi, H., Wang, C., Chen, W., Zhang, D., & Hou, L. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103405 · Cited by 3
Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders
Kumari, V., Shahrukh, M., Jabin, K., Ali, N., Hasan, N., Aqil, M., & Ahmad, F. J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214822 · Cited by 4
You, J., Maksimovic, K., Metri, M. N., Schoeppe, A., Chen, K., Lee, J., Santos, J. R., Youssef, M., Salter, M. W., & Park, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37926 · Cited by 3
Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy
Akbar, M. U., Guo, W., Shen, X. M., Fang, Y., Liu, Y., Wang, P., Elnathan, R., & Chen, Y. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500124 · Cited by 3
Farias, A. G., Feng, B., Khan, S., Ngo, W., Wu, J. L. Y., Aguilera-Uribe, M., Grewal, S., Mero, P., Singh, S. K., Kislinger, T., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115921 · Cited by 3
The Cell Culture Environment Regulates the Transcription Factor MafB in BV-2 Microglia.
Miller‐Rhodes, P., & Gelbard, H. A. (2021) · PubMed · Cited by 3
Duwat, C., Léal, P., Vautheny, A., Aurégan, G., Joséphine, C., Gaillard, M., Hérard, A., Jan, C., Gipchtein, P., Mitja, J., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106116 · Cited by 6
“Microglial phagocytic activity could also be disrupted by aging (Pluvinage et al., 2019).”
BackgroundMethodInfluentialRevisiting the advance of age-dependent α-synuclein propagation and aggregation
Song, D., & Li, J. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2024.44 · Cited by 4
Applications of CRISPR-Cas in Ageing Research
Haston, S., Pozzi, S., & González-Meljem, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_11 · Cited by 3
Yuan, Q., Liu, X., Zhang, Y., Xian, Y., Zou, J., Zhang, X., Huang, P., Song, Y., & Lin, Z. (2021) · Molecules · doi:10.3390/molecules26092685 · Cited by 3
“The absence of clearance of Aβ plaques may be due to the phagocytic deficit of microglia in aged mice [27,37].”
BackgroundEpigenetic mechanism of carbohydrate sulfotransferase 3 ( CHST3 ) downregulation in the aging brainPreprint
Baidoe‐Ansah, D., Sakib, M. S., Jia, S., Fischer, A., Kaushik, R., & Dityatev, A. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/741355 · Cited by 3
“Several studies have shown that there is a gradual age-dependent physiological increase in the neuroinflammation, which is related to activation of astrocytes and microglia (Godbout et al., 2005; Lynch, 2010), and is also thought to be involved in cognitive decline (Pluvinage et al., 2019).”
BackgroundOligomeric amyloid beta prevents myelination in a clusterin-dependent mannerPreprint
Beiter, R. M., Raghavan, T. P., Suchocki, O., Ennerfelt, H. E., Rivet-Noor, C. R., Merchak, A. R., Phillips, J. L., Bathe, T., Lukens, J. R., Prokop, S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4415143/v1 · Cited by 3
“C57BL/6J mice (8–14 weeks) were injected with CypHer-A β (ipsilateral) and NHS-Fluorescein (contralateral, Thermo Fisher 46410) as previously described [20].”
MethodShea, J. M., & Villeda, S. (2025) · eLife · doi:10.7554/elife.97671.2 · Cited by 2
Gizowski, C., Popova, G., Shin, H., Mader, M. M.-D., Craft, W., Kong, W., Shibuya, Y., Wranik, B. J., Fu, Y. H. H., Depp, C., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.09.02.673859 · Cited by 4
Cutler, R., Harrison, S., Kuhn-Sandoval, N., Tomlinson, S., & Kokovay, E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681517 · Cited by 3
“We further expanded our phagocytosis gene list to include genes identified in prior functional screens (Haney et al., 2018; Pluvinage et al., 2019), and found that all intersecting genes (9/9) were upregulated in aged microglia (Supplementary Figs.”
Pouil, S., Rigaudeau, D., Lee, B.-H., Segret, E., Desgranges, A., D’Ambrosio, J., François, Y., Boudinot, P., Duchaud, É., Phocas, F., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-12231-3 · Cited by 2
Lysakova, E. V., Burak, M., Larin, I. I., Chuvpilo, S. A., Laktyushkin, V. S., Shumeev, A. N., Pismennyi, I. E., Toshchakov, V. Y., Bobrov, M. Y., & Александрович, Р. С. (2025) · Biomedicines · doi:10.3390/biomedicines14010071 · Cited by 2
“As a result, a decline in the phagocytosis of Staphylococcus aureus by human MDMs has been observed, along with reductions in MDM migration and chemotaxis [23,25,26].”
Yan, W., Xiang, D., Du, L., Zhu, D., Jia, Q., Liu, Y., Wang, S., Liu, L., Guan, H., Zhao, Y., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114718 · Cited by 2
Shi, X., Cai, S., Chai, J.-L., Xu, C. J., Zhou, B.-Y., Han-qi, L., Marshall, J., & Cao, C. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03575-7 · Cited by 3
“The results of this study suggest that antidepressant drugs enhance TrkB-mediated expression of CD22, a negative regulator of microglia phagocytosis and in fl ammation [32], to restore microglia to a homeostatic state required for learning-related synapse formation.”
Microglial heterogeneity in neurological disorders: From dynamic states to druggable targets
Ou, Q., Dai, Z., Zhou, Y., Li, G., Liu, H., Li, J., He, C., Qin, S., & Su, Z. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117994 · Cited by 3
Ma, J., Yang, B., Jiang, X., Wang, L., Wei, W., Cao, Y., & Li, H. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113177 · Cited by 4
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
“CD22 is upregulated in aged microglia, and its blockade restores a more homeostatic transcriptional state and improves cognition [322].”
Rogerson‐Wood, L., Goldsbury, C. S., Sawatari, A., & Leamey, C. A. (2024) · Glia · doi:10.1002/glia.24522 · Cited by 2
“…been reported in various human neurodevelopmental conditions including autistic spectrum disorders (Openshaw et al., 2023; Takeguchi et al., 2022; Xie et al., 2023) and associated mouse models (Bertero et al., 2018; Carroll et al., 2021; Jain et al., 2020; Kennedy et al., 2020; Smith et al., 2019).”
BackgroundZhang, Y., Hu, Z.-X., Zhang, S., Liu, L., Galán, M. C., Voglmeir, J., & Ghirardello, M. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00752 · Cited by 2
Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions
Greenfield, A. L., & Hauser, S. L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00740-5 · Cited by 2
Quintana, J. F., Chandrasegaran, P. R. G., Sinton, M. C., Briggs, E. M., Otto, T. D., Heslop, R., Bentley-Abbot, C., Loney, C., de Lecea, L., Mabbott, N. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.25.485502 · Cited by 2
Lu, R. J., Chen, S., Kim, M., Sampathkumar, N. K., Lee, E. H., Christensen, A., Wang, E., Lau, I. C. Y., Parihar, S., Ravikumar, C. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.11.659200 · Cited by 2
Ouyang, Y., Che, S., Whitehead, E. C., Poysungnoen, K., Agarwal, A., Liu, A., Newman, H., Silinski, P., Becker, M. L., & Segura, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.10.674054 · Cited by 2
An Agent-Based Model of Microglia and Neuron Interaction: Implications in Neurodegenerative Disease
Ty, C., Case, A., Mezzulo, E., Penland, A., & Larripa, K. (2025) · Spora A Journal of Biomathematics · doi:10.61403/2473-5493.1097 · Cited by 1
Zhang, X., Xu, H., Ren, X.-W., Li, Q.-X., Hong, C., Chen, Y.-F., Yang, J., Ji, J., Guo, R., & Sun, X. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107020 · Cited by 2
“Microglia, the brain ’ s resident phagocytes, clear dead cells, neuronal debris, synapses, and even mildly damaged neurons with potential for recovery(Brown, 2021; Brown and Neher, 2010, 2014; Otxoa-de-Ame-zaga et al., 2019; Pluvinage et al., 2019).”
Glial-mediated pathogenesis and intervention strategies in neuromyelitis optica spectrum disorder
Zhang, Z., Li, F., Li, X., & Wei, H. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106666 · Cited by 1
Roles of the phagocytosis checkpoint in radiotherapy
Kui, Y., Tong, F., Zhang, R., Wang, J., & Dong, X. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07921-5 · Cited by 1
“…cluster of differentiation 24(CD24)-sialic acid binding Ig like lectin 10(Siglec-10) (in 2019) [42], cluster of differentiation 22 (CD22) (in 2019) [43], signaling lymphocytic activation molecule family 3/4 (SLAMF3/4) (in 2022) [44] and ganglioside 2 (GD2)-sialic acid binding Ig like lectin 7…”
Sialylation patterns in cerebral amyloid angiopathy
Fastenau, C., Crisp, R., Keating, M., Ochoa, E., Richardson, T. E., Flanagan, M. E., Walker, J. M., Hopp, S. C., & Bieniek, K. F. (2025) · Brain Pathology · doi:10.1111/bpa.70042 · Cited by 2
“SA residues contribute to the biophysical property of repulsion due to the negative charge of cells [15].”
Hu, D., Li, X., Li, Y., Zhang, Q., Dai, Y., Teng, X., Hou, H., & Li, J. (2025) · ChemBioChem · doi:10.1002/cbic.202500515 · Cited by 1
Kukan, E. N., Fabiano, G. L., Zhou, J. Y., Richard, A. R., Telfer, K., & Cobb, B. A. (2025) · Glycobiology · doi:10.1093/glycob/cwaf076 · Cited by 1
Xu, L., Zhou, Y., Yang, H. K., Chen, X., & Ouyang, Q. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115596 · Cited by 2
Aurka-Bhlhe41 axis prevents premature aging-like microglial dysfunction and promotes remyelination
Yan, W., Zhao, Y., Li, H., Hong, L., Jia, Q., Zhu, D., Xiang, D., Du, L., Hu, L., Bai, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71014-w · Cited by 1
“Targeting CD22 with neutralizing antibodies restores aging microglial function and promotes CNS homeostasis 16 .”
InfluentialThe Roles of Macrophage Lineage Cells ( MLC s) in Brain Aging
Qin, Q., Zhang, L., Guo, M., Lu, D., Liu, Y., Wang, Z., Hu, M., Wang, S., Kang, X., Yi, H., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70873 · Cited by 1
He, C., Shi, H., Yu, Z., Jiao, Z., Li, J., & Yang, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1804207 · Cited by 2
“In the aging brain, there is a change in the transcriptional and epigenetic status of microglia, showing increased baseline expression of in fl amma-tory genes, which is termed the “ aged ” or “ primed ” state of microglia (27).”
Bang-feng, L., Chen, X., Xie, R., Mo, Y.-F., Wu, Y.-Z., Meng, Y., Han, X.-L., Chen, M., & Peng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1818802 · Cited by 2
“For instance, microglial phagocytosis can be restored by inhibiting the CD22 receptor or hexokinase 2, while targeting EP2/4 receptors can revitalize microglial energy metabolism by reprogramming glucose and glycogen utilization (188 – 190).”
Microglial state transitions are constrained by developmental and metabolic checkpoints
Mesaoudi, A. E., & Kim, D. W. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1852176 · Cited by 1
“Examples include CD22 blockade, which restores phagocytic function in aged microglia by relieving an age-associated inhibitory signal (Pluvinage et al., 2019), and CD33 modulation, which alters microglial engagement with amyloid (Griciuc et al., 2013).”
Song, C., Lee, Y., & Kim, M. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1813048 · Cited by 1
“CD22, an inhibitory receptor upregulated in aged microglia in murine models, has been shown to suppress phagocytic capacity including myelin debris clearance (69).”
Microglial ITAM & ITIM Signaling in Neurodegenerative Disease and Brain Aging
Mangalmurti, A., Bonheur, A., & Lukens, J. R. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169910 · Cited by 1
He, M., Wu, C., Hu, M., Shi, X., Liu, R., Tong, Y., Wang, H., Hu, H., & Liao, H. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03925-w · Cited by 1
“Although BV2 cells cannot fully recapitulate the features of primary microglia, they exhibit similar phagocytic machinery [37].”
Combating ageing beyond the cell: Emerging roles of extracellular proteostasis
Venkatesh, S. R., Gallotta, I., Olabiyi, B. F., Choi, Y. H., Inglesfield, S., Kumita, J. R., Ewald, C. Y., & David, D. C. (2026) · FEBS Journal · doi:10.1111/febs.70647 · Cited by 2
“With age, the recognition of aggregates and their phagocytosis by microglia is impaired [207,208].”
Su, B., Dong, W., Su, L., Ye, J., Yao, Q., Liu, M., Wu, J., & Du, K. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108344 · Cited by 2
CD22 regulates Aβ clearance in microglia through INPP5D signaling
Zou, D.-Z., Li, J., Long, Q.-S., Zhang, R., Zhu, B.-L., & Tan, J.-Z. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1886995 · Cited by 1
“Recent work has detected CD22 in aging-associated microglia, where it acts as a negative regulator of phagocytosis (Pluvinage et al., 2019).”
Influentialα2,6-Sialoglycan-regulated antitumor immunity of tumor-infiltrating CD8+ T cells
Liang, S., Tang, Q., Guo, Y., Zhang, S., Song, Q., Dai, P., & Chen, X. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02299-7 · Cited by 1
“Concurrently, sialoglycans on immune cells are dynamically regulated, and this has substantial functional implications 17–24 .”
Singh, S., & Singh, S. K. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00166 · Cited by 1
Mouse model of repetitive mild traumatic brain injury (investigating cognitive impairment)
Li, L., Nguyen, A., & Luo, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89833-1.00007-0 · Cited by 1
Self-citationNew Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230427100702 · Cited by 2
Church, K. A., Cardona, A. E., & Hopp, S. C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_15 · Cited by 1
In situ neuroregeneration: frontiers and therapeutic prospects
Wang, Q., Li, W., Lei, W., Chen, W., Zheng, J., Xiang, Z., MinHui, L. I. U., He, Q., Xu, L., Li, Z., et al. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0024 · Cited by 1
Metadata
- Authors
- Pluvinage, J. V., Haney, M. S., Smith, B. A. H., Sun, J., Iram, T., Bonanno, L., Li, L., Lee, D. P., Morgens, D. W., Yang, A. C., Shuken, S. R., Gate, D., Scott, M., Khatri, P., Luo, J., Bertozzi, C. R., Bassik, M. C., & Wyss-Coray, T.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Nature
- Published
- 2019-04
- Volume
- 568
- Issue
- 7751
- Pages
- 187-192
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6574119
- OpenAlex
- W2934339908
- Cited by
- 459
- References
- 71
- Citations by year
- 2026: 44 · 2025: 73 · 2024: 62 · 2023: 70 · 2022: 71 · 2021: 59 · 2020: 54 · 2019: 26
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (1s10od020141-01)
- National Institute on Aging (F30AG060638, R01AG045034, DP1AG053015)
- National Human Genome Research Institute (T32HG000044)
- National Cancer Institute (R01CA227942)
- National Institute of General Medical Sciences (T32GM120007, T32GM007365, R01GM059907)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- CD22, microglial phagocytosis, brain aging, microglial homeostasis, sialic acid, myelin debris clearance, amyloid-beta oligomers, alpha-synuclein fibrils, cognitive decline, antibody therapy, CRISPR-Cas9 screen, neurodegeneration
- MeSH terms
- CRISPR-Associated Protein 9, Aging, Animals, Brain, Cognition, Female, Homeostasis, Male, Mice, Inbred C57BL, Phagocytosis, Sequence Analysis, RNA, Microglia, N-Acetylneuraminic Acid, Mice, Sialic Acid Binding Ig-like Lectin 2, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review